Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 1/20 | 0.40 |
| ▸ | PDK2 | Q15119 | 11/20 | 0.38 |
| ▸ | BIRC5 | O15392 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.33 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19822234 | 1.00 | TDP2 (0.40) | TDP2PDK2BIRC5CA12CA1 | |
| SCHEMBL19151960 | 0.92 | PDK2 (0.38) | PDK2CA12CA1CA2CA9 | |
| SCHEMBL19822213 | 0.92 | PDK2 (0.37) | PDK2CA12CA1CA2CA9 | |
| SCHEMBL19797298 | 0.92 | PDK2 (0.37) | PDK2CA12CA1CA2CA9 | |
| SCHEMBL19822254 | 0.91 | TDP2 (0.40) | TDP2PDK2BIRC5CA12CA1 | |
| SCHEMBL19797317 | 0.91 | TDP2 (0.40) | TDP2PDK2BIRC5CA12CA1 | |
| SCHEMBL19797302 | 0.86 | PDK2 (0.36) | PDK2CA12CA1CA2CA9 | |
| SCHEMBL19822208 | 0.86 | TDP2 (0.38) | TDP2PDK2BIRC5CA12CA1 | |
| SCHEMBL19822241 | 0.86 | PDK2 (0.36) | PDK2CA12CA1CA2CA9 | |
| SCHEMBL19797290 | 0.86 | TDP2 (0.38) | TDP2PDK2BIRC5CA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180026187-A1 | NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180026187-A1 | NOVEL COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE COMPRISING SAME | EBPL, OR51E2, EML4 | TDP2 2966/4885PDK2 1847/4885BIRC5 3066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.